37,436
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Diagnostic criteria and contributors to Gilbert’s syndrome

, , , &
Pages 129-139 | Received 04 Nov 2017, Accepted 12 Jan 2018, Published online: 01 Feb 2018

References

  • Jeney V, Eaton JW, Balla G, et al. Natural history of the bruise: formation, elimination, and biological effects of oxidized hemoglobin. Oxid Med Cell Longev. 2013;2013:703571.
  • Blaschke TF, Berk PD, Scharschm BF, et al. New approach to the estimation of early-labeled peak synthesis in man. In: Berk PD, Berlin NI, editors. Chemistry and Physiology of Bile Pigments. Bethesda: National Institutes of Health; 1977. p. 539.
  • Pimstone NR, Tenhunen R, Seitz PT, et al. The enzymatic degradation of hemoglobin to bile pigments by macrophages. J Exp Med. 1971;133:1264–1281.
  • Wegiel B, Baty CJ, Gallo D, et al. Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J Biol Chem. 2009;284:21369–21378.
  • Kamisako T, Kobayashi Y, Takeuchi K, et al. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol. 2000;35:659–664.
  • Vitek L, Majer F, Muchova L, et al. Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;833:149–157.
  • Berk PD, Berlin NI, editors. Chemistry and physiology of bile pigments. Bethesda: National Institutes of Health; 1977.
  • McDonagh AF, Palma LA, Schmid R. Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig. Biochem J. 1981;194:273–282.
  • Horsfall LJ, Nazareth I, Pereira SP, et al. Gilbert's syndrome and the risk of death: a population-based cohort study. J Gastroenterol Hepatol. 2013;28:1643–1647.
  • Horsfall LJ, Rait G, Walters K, et al. Serum bilirubin and risk of respiratory disease and death. JAMA. 2011;305:691–697.
  • Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–1046.
  • Lazcano A. Planetary change and biochemical adaptation: molecular evolution of corrinoid and heme biosyntheses. Hematology. 2012;17(Suppl 1):S7–S10.
  • Wegiel B, Nemeth Z, Correa-Costa M, et al. Heme oxygenase-1: a metabolic nike. Antioxid Redox Signal. 2014;20:1709–1722.
  • Hull TD, Agarwal A, George JF. The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1. Antioxid Redox Signal. 2014;20:1770–1788.
  • Cornelius CE. Bile pigments in fishes: a review. Vet Clin Pathol. 1991;20:106–115.
  • Lightner DA, McDonagh AF. Structure and metabolism of natural and synthetic bilirubins. J Perinatol. 2001;21(Suppl 1):S13–S16.
  • Bulmer AC, Coombes JS, Blanchfield JT, et al. Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration. Br J Pharmacol. 2011;164:1857–1870.
  • McDonagh AF. Controversies in bilirubin biochemistry and their clinical relevance. Semin Fetal Neonatal Med. 2010;15:141–147.
  • Mendez L, Lagoa M, Quiroga T, et al. [Prevalence of Gilbert syndrome and its genetic determinants in Chile]. Rev Med Chil. 2013;141:1266–1274. Spanish.
  • Owens D, Evans J. Population studies on Gilbert's syndrome. J Med Genet. 1975;12:152–156.
  • Gwee KA, Koay ES, Kang JY. The prevalence of isolated unconjugated hyperbilirubinaemia (Gilbert's syndrome) in subjects attending a health screening programme in Singapore. Singapore Med J. 1992;33:588–589.
  • Hemmati F, Saki F, Saki N, et al. Gilbert syndrome in Iran, Fars Province. Ann Saudi Med. 2010;30:84.
  • Sieg A, Arab L, Schlierf G, et al. [Prevalence of Gilbert's syndrome in Germany]. Dtsch Med Wochenschr. 1987;112:1206–1208. German.
  • Soos P. [The prevalence of hyperbilirubinaemia and the diagnostics of Gilbert-syndrome in our work fitness examinations]. Orv Hetil. 2007;148:2139–2142. Hungarian.
  • Kadlckova L, Danzig V, Cifkova R, et al. Prevalence of Gilbert syndrome and UGT1A1*28 status in the Czech population, and their relationship to ischemic heart disease. Atherosclerosis. 2014;235:e285–e286.
  • Bailey A, Robinson D, Dawson AM. Does Gilbert's disease exist? Lancet. 1977;1:931–933.
  • Ando Y, Chida M, Nakayama K, et al. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics. 1998;8:357–360.
  • Johnson AD, Kavousi M, Smith AV, et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet. 2009;18:2700–2710.
  • Lin JP, O'Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006;114:1476–1481.
  • Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage-mechanisms and management approaches. N Engl J Med. 2013;369:2021–2030.
  • Gazzin S, Tiribelli C. Bilirubin-induced neurological damage. J Matern Fetal Neonatal Med. 2011;24(Suppl 1):154–155.
  • Kwon YJ, Lee YJ, Park BJ, et al. Total serum bilirubin and 8-year incident type 2 diabetes mellitus: The Korean Genome and Epidemiology Study. Diabetes Metab. 2017 [Aug 21]. DOI:10.1016/j.diabet.2017.07.004
  • Wagner KH, Wallner M, Molzer C, et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci. 2015;129:1–25.
  • Gilbert A, Lereboullet P. La cholamae simple familiale [The simple hereditary cholestasis]. Sem Med. 1901;21:241–248. French.
  • Arias IM. Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. J Clin Invest. 1962;41:2233–2245.
  • RCPA Manual, The Royal College of Pathologists of Australia [Internet]. Entry on bilirubin. 2015 [cited 2018 Jan 9]. Available from: https://www.rcpa.edu.au/Library/Practising-Pathology/RCPA-Manual/Items/Pathology-Tests/B/Bilirubin
  • Royal College of Physicians and Surgeons of Canada. Clinical laboratory tests – reference values. 2017 [cited 2018 Jan 9]. Available from: http://www.royalcollege.ca/rcsite/documents/credential-exams/clinical-lab-tests-reference-values-e.pdf
  • Powell LW, Hemingway E, Billing BH, et al. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study. N Engl J Med. 1967;277:1108–1112.
  • Powell LW. Clinical aspects of unconjugated hyperbilirubinemia. Semin Hematol. 1972;9:91–105.
  • Chiddarwar AS, D'Silva SZ, Colah RB, et al. Genetic variations in bilirubin metabolism genes and their association with unconjugated hyperbilirubinemia in adults. Ann Hum Genet. 2017;81:11–19.
  • Shortland DB, Hussey M, Chowdhury AD. Understanding neonatal jaundice: UK practice and international profile. J R Soc Promot Health. 2008;128:202–206.
  • Mishra JP, Mishra J, Padhi RK, et al. Hematological profile in neonatal jaundice. J Basic Clin Physiol Pharmacol. 2014;25:225–228.
  • Buyukasik Y, Akman U, Buyukasik NS, et al. Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome. Am J Med Sci. 2008;335:115–119.
  • Sarlak H, Arslan E, Cakar M, et al. Relation between unconjugated bilirubin and RDW, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio in Gilbert's syndrome. Springerplus. 2016;5:1392.
  • Wallner M, Bulmer AC, Moelzer C, et al. Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome. Eur J Clin Invest. 2014;43:912–919.
  • Berk PD, Bloomer JR, Howe RB, et al. Bilirubin production as a measure of red cell life span. J Lab Clin Med. 1972;79:364–378.
  • Cartei G, Chisesi T, Cazzavillan M, et al. Red blood cell survival and hyperbilirubinaemia in the Gilbert's syndrome. Folia Haematol Int Mag Klin Morphol Blutforsch. 1976;103:93–100.
  • Kutz K, Egger G, Bachofen H, et al. Effect of fasting on endogenous carbon monoxide production in normal subjects and those with constitutional hepatic dysfunction (Gilbert's syndrome). In: Berk PD, Berlin NI, editors. Chemistry and Physiology of Bile Pigments. Bethesda: National Institutes of Health; 1977. p. 156–167.
  • Powell LW, Billing BH, Williams HS. An assessment of red cell survival in idiopathic unconjugated hyperbilirubinaemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium. Australas Ann Med. 1967;16:221–225.
  • Brito MA, Brondino CD, Moura JJ, et al. Effects of bilirubin molecular species on membrane dynamic properties of human erythrocyte membranes: a spin label electron paramagnetic resonance spectroscopy study. Arch Biochem Biophys. 2001;387:57–65.
  • Brito MA, Silva RF, Brites D. Bilirubin induces loss of membrane lipids and exposure of phosphatidylserine in human erythrocytes. Cell Biol Toxicol. 2002;18:181–192.
  • Brito MA, Brites D. Effect of acidosis on bilirubin-induced toxicity to human erythrocytes. Mol Cell Biochem. 2003;247:155–162.
  • Bulmer AC, Blanchfield JT, Coombes JS, et al. In vitro permeability and stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorg Med Chem. 2008;16:3616–3625.
  • Minami H, Asada T, Gan K, et al. Successful operation for mitral regurgitation in a patient with Gilbert's syndrome. Gen Thorac Cardiovasc Surg. 2011;59:344–346.
  • Mendez-Sanchez N, Gonzalez V, Flores A, et al. Delayed gastric emptying in subjects with Gilbert's syndrome. Hepatogastroenterology. 2001;48:1183–1185.
  • McArdle PF, Whitcomb BW, Tanner K, et al. Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference. BMC Cardiovasc Disord. 2012;12:16.
  • Zhou J, Tracy TS, Remmel RP. Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors. Drug Metab Dispos. 2011;39:322–329.
  • Radlovic N, Lekovic Z, Mladenovic M, et al. [Gilbert's syndrome in children–our experience]. Srp Arh Celok Lek. 2007;135:317–320. Serbian
  • Deetman PE, Bakker SJ, Kwakernaak AJ, et al. The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects. PLoS One. 2014;9:e90886.
  • Watchko JF, Lin Z. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med. 2010;15:169–175.
  • Tirona RG, Leake BF, Merino G, et al. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem. 2001;276:35669–35675.
  • Sanna S, Busonero F, Maschio A, et al. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet. 2009;18:2711–2718.
  • Alencastro de Azevedo L, Reverbel da Silveira T, Carvalho CG, et al. UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association? Pediatr Res. 2012;72:169–173.
  • Caglayan S, Candemir H, Aksit S, et al. Superiority of oral agar and phototherapy combination in the treatment of neonatal hyperbilirubinemia. Pediatrics. 1993;92:86–89.
  • Cuperus FJ, Iemhoff AA, van der Wulp M, et al. Acceleration of the gastrointestinal transit by polyethylene glycol effectively treats unconjugated hyperbilirubinaemia in Gunn rats. Gut. 2010;59:373–380.
  • Nishioka T, Hafkamp AM, Havinga R, et al. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats. J Pediatr. 2003;143:327–334.
  • Strassburg CP. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol. 2010;24:555–571.
  • Rastogi A, Krishnani N, Pandey R. Dubin-Johnson syndrome–a clinicopathologic study of twenty cases. Indian J Pathol Microbiol. 2006;49:500–504.
  • Erlinger S, Arias IM, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology. 2014;146:1625–1638.
  • Ritter JK, Crawford JM, Owens IS. Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem. 1991;266:1043–1047.
  • Seppen J, Bosma PJ, Goldhoorn BG, et al. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest. 1994;94:2385–2391.
  • Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171–1175.
  • Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA. 1998;95:8170–8174.
  • den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15:7–12.
  • Monaghan G, Ryan M, Hume R, et al. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet. 1996;347:578–581.
  • Sato H, Adachi Y, Koiwai O. The genetic basis of Gilbert's syndrome. Lancet. 1996;347:557–558.
  • Maruo Y, Nishizawa K, Sato H, et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics. 1999;103:1224–1227.
  • van de Steeg E, Stranecky V, Hartmannova H, et al. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest. 2012;122:519–528.
  • Levine RL, Fredericks WR, Rapoport SI. Clearance of bilirubin from rat brain after reversible osmotic opening of the blood-brain barrier. Pediatr Res. 1985;19:1040–1043.
  • Jendrassik L, Grof P. Photometric determination of bilirubin in urine. Biochem Zeitschrift. 1938;296:71–79.
  • Mizobe M, Kondo F, Kumamoto K, et al. High-performance liquid chromatographic analysis of bilirubin and biliverdin from jaundiced broilers. J Vet Med Sci. 1997;59:677–680.
  • Mizobe M, Kondo F, Kumamoto K, et al. Rapid and quantitative analysis of bilirubin in equines by high-performance liquid chromatography. Microbios. 1996;86:39–47.
  • Saxerholt H, Skar V, Midtvedt T. HPLC separation and quantification of bilirubin and its glucuronide conjugates in faeces and intestinal contents of germ-free rats. Scand J Clin Lab Invest. 1990;50:487–495.
  • Doumas BT, Wu TW. The measurement of bilirubin fractions in serum. Crit Rev Clin Lab Sci. 1991;28:415–445.
  • Kuenzle CC, Maier C, Ruttner JR. The nature of four bilirubin fractions from serum and of three bilirubin fractions from bile. J Lab Clin Med. 1966;67:294–306.
  • Zelenka J, Lenicek M, Muchova L, et al. Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;867:37–42.
  • Wallner M, Marculescu R, Doberer D, et al. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci. 2013;125:257–264.
  • Bakrania B, Du Toit EF, Ashton KJ, et al. Chronically elevated bilirubin protects from cardiac reperfusion injury in the male Gunn rat. Acta Physiol. 2017;220:461–470.
  • Bakrania B, Du Toit EF, Wagner KH, et al. Pre- or post-ischemic bilirubin ditaurate treatment reduces oxidative tissue damage and improves cardiac function. Int J Cardiol. 2016;202:27–33.
  • Diamond I, Schmid R. Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system. J Clin Invest. 1966;45:678–689.
  • Rodriguez Garay EA, Scremin OU. Transfer of bilirubin- 14 C between blood, cerebrospinal fluid, and brain tissue. Am J Physiol. 1971;221:1264–1270.
  • Okamura Y, Yamazaki M, Yamaguchi T, et al. Anti-bilirubin monoclonal antibody. III. Preparation and properties of monoclonal antibodies to unconjugated bilirubin-IX alpha. Biochim Biophys Acta. 1991;1073:538–542.
  • Kimpara T, Takeda A, Yamaguchi T, et al. Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. Neurobiol Aging. 2000;21:551–554.
  • Otani K, Shimizu S, Chijiiwa K, et al. Administration of bacterial lipopolysaccharide to rats induces heme oxygenase-1 and formation of antioxidant bilirubin in the intestinal mucosa. Dig Dis Sci. 2000;45:2313–2319.
  • Nakayama M, Takahashi K, Komaru T, et al. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001;21:1373–1377.
  • van den Bergh AAH. Diazo test for bilirubin in blood. JAMA. 1921;77:235.
  • Doumas BT, Yein F, Perry B, et al. Determination of the sum of bilirubin sugar conjugates in plasma by bilirubin oxidase. Clin Chem. 1999;45:1255–1260.
  • Bulmer AC, Blanchfield JT, Toth I, et al. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis. 2008;199:390–396.
  • Heirwegh KP, Blanckaert N, Van Hees G. Synthesis, chromatographic purification, and analysis of isomers of biliverdin IX and bilirubin IX. Anal Biochem. 1991;195:273–278.
  • Heirwegh KP, Fevery J, Blanckaert N. Chromatographic analysis and structure determination of biliverdins and bilirubins. J Chromatogr. 1989;496(1):1–26.
  • Blanckaert N, Kabra PM, Farina FA, et al. Measurement of bilirubin and its monoconjugates and diconjugates in human serum by alkaline methanolysis and high-performance liquid chromatography. J Lab Clin Med. 1980;96:198–212.
  • Rubaltelli FF, Gourley GR, Loskamp N, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics. 2001;107:1264–1271.
  • Wu TW. Bilirubin analysis the state of the art and future prospects. Clin Biochem. 1984;17:221–229.
  • McDonagh AF, Lightner DA, Kar AK, et al. Hepatobiliary excretion of biliverdin isomers and C10-substituted biliverdins in Mrp2-deficient (TR(-)) rats. Biochem Biophys Res Commun. 2002;293:1077–1083.
  • Iwamori S, Sato E, Saigusa D, et al. A novel and sensitive assay for heme oxygenase activity. Am J Physiol Renal Physiol. 2015;309:F667–F671.